Skip to main content

Talking Genomic Medicine and More

Science Progress is encouraged by the upcoming meeting of the Secretary’s Advisory Committee for Genetics, Health, and Society at the Department of Health and Human Services, saying that this sort of federal-level discussion of the future of genomic medicine is just what is needed. The SACGHS meeting tomorrow will run the gamut from comparative effectiveness research to sharing genomic data and Science Progress hopes that it will "[allow] scientists, policymakers, innovators, service providers, and patients to work together to ensure that this new era of medical innovation serves the common good by being safe, effective, efficient, and equitable."

The Scan

Not Kept "Clean and Sanitary"

A Food and Drug Administration inspection uncovered problems with cross contamination at an Emergent BioSolutions facility, the Wall Street Journal reports.

Resumption Recommendation Expected

The Washington Post reports that US officials are expected to give the go-ahead to resume using Johnson & Johnson's SARS-CoV-2 vaccine.

Canada's New Budget on Science

Science writes that Canada's new budget includes funding for the life sciences, but not as much as hoped for investigator-driven research.

Nature Papers Examine Single-Cell, Multi-Omic SARS-CoV-2 Response; Flatfish Sequences; More

In Nature this week: single-cell, multi-omics analysis provides insight into COVID-19 pathogenesis, evolution of flatfish, and more.